| Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised … B Nordlinger, H Sorbye, B Glimelius, GJ Poston, PM Schlag, P Rougier, ... The Lancet 371 (9617), 1007-1016, 2008 | 2324 | 2008 |
| Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised … B Nordlinger, H Sorbye, B Glimelius, GJ Poston, PM Schlag, P Rougier, ... The lancet oncology 14 (12), 1208-1215, 2013 | 1282 | 2013 |
| Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ... The lancet oncology 6 (9), 659-668, 2005 | 1110 | 2005 |
| Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer S Chan, K Friedrichs, D Noel, T Pintér, S Van Belle, D Vorobiof, R Duarte, ... Journal of Clinical Oncology 17 (8), 2341-2341, 1999 | 823 | 1999 |
| SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation … GA Van Hazel, V Heinemann, NK Sharma, MPN Findlay, J Ricke, ... Journal of Clinical Oncology 34 (15), 1723-1731, 2016 | 396 | 2016 |
| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE … HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ... The Lancet Oncology 18 (9), 1159-1171, 2017 | 374 | 2017 |
| Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial BH Burmeister, JM Thomas, EA Burmeister, ET Walpole, JA Harvey, ... European journal of cancer 47 (3), 354-360, 2011 | 370 | 2011 |
| Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer JF Bishop, J Dewar, GC Toner, J Smith, MHN Tattersall, IN Olver, ... Journal of Clinical Oncology 17 (8), 2355-2355, 1999 | 264 | 1999 |
| High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-TROG 96: 07 M Poulsen, D Rischin, E Walpole, J Harvey, J Mackintosh, J Ainslie, ... Journal of Clinical Oncology 21 (23), 4371-4376, 2003 | 255 | 2003 |
| Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? MG Poulsen, D Rischin, I Porter, E Walpole, J Harvey, C Hamilton, ... International Journal of Radiation Oncology* Biology* Physics 64 (1), 114-119, 2006 | 205 | 2006 |
| Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent … V Durbecq, M Paesmans, F Cardoso, C Desmedt, A Di Leo, S Chan, ... Molecular cancer therapeutics 3 (10), 1207-1214, 2004 | 173 | 2004 |
| Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma A Coates, D Thomson, GRM McLeod, P Hersey, PG Gill, IN Olver, ... European Journal of Cancer 29 (12), 1731-1734, 1993 | 171 | 1993 |
| Cisplatin‐based therapy: a neurological and neuropsychological review L Troy, K McFarland, S Littman‐Power, BJ Kelly, ET Walpole, D Wyld, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2000 | 164 | 2000 |
| Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 O Hamid, C Robert, A Ribas, FS Hodi, E Walpole, A Daud, AS Arance, ... British journal of cancer 119 (6), 670-674, 2018 | 137 | 2018 |
| The role of the GP in follow-up cancer care: a systematic literature review JA Meiklejohn, A Mimery, JH Martin, R Bailie, G Garvey, ET Walpole, ... Journal of Cancer Survivorship 10, 990-1011, 2016 | 137 | 2016 |
| Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983) H Sorbye, M Mauer, T Gruenberger, B Glimelius, GJ Poston, PM Schlag, ... Annals of surgery 255 (3), 534-539, 2012 | 135 | 2012 |
| Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially … B Nordlinger, H Sorbye, L Collette, B Glimelius, GJ Poston, PM Schlag, ... Journal of Clinical Oncology 25 (18_suppl), LBA5-LBA5, 2007 | 122 | 2007 |
| Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies HY Chew, PO De Lima, JLG Cruz, B Banushi, G Echejoh, L Hu, ... Cell 180 (5), 895-914. e27, 2020 | 117 | 2020 |
| Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation TP Haines, P Sinnamon, NG Wetzig, M Lehman, E Walpole, T Pratt, ... Breast cancer research and treatment 124, 163-175, 2010 | 107 | 2010 |
| A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma KD Lewis, WA Robinson, MJ Millward, A Powell, TJ Price, DB Thomson, ... Investigational new drugs 26, 89-94, 2008 | 105 | 2008 |
